Autoimmune hemolytic anemia in a patient with acute myelogenous leukemia treated with low-dose interleukin-2 after autologous bone marrow transplantation [letter]
暂无分享，去创建一个
[1] Caligiuri Ma. Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications. , 1993 .
[2] T. Taniguchi,et al. The IL-2 receptor complex: its structure, function, and target genes. , 1993, Annual review of immunology.
[3] M. Caligiuri,et al. Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Kendall A. Smith,et al. Interleukin-2: inception, impact, and implications. , 1988, Science.